EUCTR2005-004475-37-GB进行中（未招募）1 期
Comparative study of the bioactivity of the HFA Fluticasone Dipropionate via current delivery devices - Systemic bioactivity of fluticasone via current delivery devices. Ver 1
niversity of Dundee ( Research & Innovation Services)0 个研究点目标入组 20 人开始时间: 2005年10月31日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1.Mild to moderate stable asthmatics on =800µg BDP or equivalent
- •2.Male or female 18-65
- •3.Informed Consent
- •4.Ability to comply with the requirements of the protocol
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1.Severe asthmatics as defined by an FEV1= 60% or PEF variability > 30% or
- •with continual daytime or nocturnal symptoms.
- •2.The use of oral corticosteroids within the last 3 months.
- •3.Recent respiratory tract infection (2 months).
- •4.Significant concomitant respiratory disease such as COPD, CF, ABPA,
- •bronchiectasis and active pulmonary tuberculosis.
- •5.Any other clinically significant medical condition such as unstable angina,
- •acute myocardial infarction in the preceding 3 months, recent TIA/
- •CVA, that may endanger the health or safety of the participant, or
- •jeopardise the protocol.
- •6.Any significant abnormal laboratory result as deemed by the investigators
- •7.Pregnancy, planned pregnancy or lactation
- •8.Known or suspected contra-indication to any of the IMP’s
- •9.Concomitant use of medicines (prescribed, over the counter or herbal) that
- •may interfere with the trial
研究者
相似试验
进行中（未招募）
1 期
COMPARATIVE STUDY OF THE SYSTEMIC BIOACTIVITY OF HFA FLUTICASONE PROPIONATE VIA ANTI-STATIC SPACER DEVICES - Systemic Bioactivity of Fluticsone via antistatic spacer devices Ver1Bronchial AsthmaEUCTR2005-005557-22-GBniversity of Dundee (Research & Innovation)20
进行中（未招募）
不适用
Evaluation des effets de la 9 alpha fluorohydrocortisone sur la réponse pressive à la noradrénaline, la perfusion gastrique, le débit huméral et la rigidité artérielle dans le choc septique. - FLUDROChoc septique.MedDRA version: 9.1Level: LLTClassification code 10040070Term: Septic shockMedDRA version: 9.1Level: LLTClassification code 10040580Term: Shock septicMedDRA version: 9.1Level: PTClassification code 10040070Term: Septic shockEUCTR2007-007971-18-FRC.H.U. de RENNES
进行中（未招募）
1 期
Comparative Relative Lung Bioavailability of HFA-Seretide via spacer devices in healthy volunteers - Lung Bioavailability of HFA-Seretide via spacersBronchial AsthmaEUCTR2007-003627-20-GBniversity of Dundee, Research & Innovation Services20
进行中（未招募）
3 期
Efficacy of Newer Polyethersulfone Dialyzers in Comparison to Standard DialyzersCTRI/2021/01/030330Sanjay Gandhi Postgraduate Institute of Medical Sciences Lucknow India
尚未招募
2 期
Clinical study for the treatment of sciatica with cuppingCTRI/2020/05/025305Regional Research Institute of Unani Medicine